Licensing, the reagents are only the building bloc
Post# of 148154
(Total Views: 965)
Posted On: 12/11/2020 10:47:42 PM
Re: reallypeople? #67979
Licensing, the reagents are only the building blocks, R&D costs will still be necessary to develop an assay by whatever company pursues it. The market for that assay is not huge; Orion, Phizer, Takeda and the recent entry BMS are the only companies beside CYDY that would be customers, that I know of.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼